Skip to content

Clinical Observation of Ziyinliangxue Decoction Combined with Moxibustion in Treating Chronic Glomerulonephritis with Deficiency of Qi and Yin

Clinical Observation of Ziyinliangxue Decoction Combined with Moxibustion in Treating Chronic Glomerulonephritis with Deficiency of Qi and Yin

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003646
Enrollment
Unknown
Registered
2020-08-23
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic glomerulonephritis

Interventions

Sponsors

Shanghai Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for chronic nephritis and the TCM criteria for Qi and Yin deficiency and blood stasis syndrome; 2. The 24-hour urine protein quantitative is 0.2g/24h-3.0g/24h; 3. Kidney function is within the normal range; 4. Aged 18-80 years old; 5. Hypertension, severe infections, water, electrolyte and acid-base balance disorders are effectively controlled, and blood potassium is within the normal range; 6. Accept the observation of this clinical trial voluntarily, have good compliance, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with unilateral or bilateral renal artery stenosis; 2. Patients with poor blood pressure control, SBP>160mmHg, or DBP>100mmHg; 3. Malignant tumor disease, hematological disease, neuropsychiatric disease or complicated disease (such as diabetes, hypertension) poorly controlled; 4. Pregnant or lactating women; 5. People with allergies or known allergies to test drug components; 6. Patients who participated in other clinical trials within the past 1 month; 7. The 24-hour urine protein quantitative is less than 0.2g/24h or greater than 3g/24h.

Design outcomes

Primary

MeasureTime frame
Urine routine;T cell subsets;Immunoglobulin;Urine Albumin/Urine Creatinine;Complement C3;24-hour urine protein quantification;

Secondary

MeasureTime frame
Serum uric acid;Blood creatinine;Serum urea nitrogen;

Countries

China

Contacts

Public ContactWang Qian

Shanghai Traditional Chinese Medicine Hospital

wangqianwater1988@163.com+86 18121005960

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026